Randomized comparative study on efficacy and safety of reduced-dose steroid combined with tacrolimus vs conventional-dose steroid in late- or elderly-onset myasthenia gravis patients
Not Applicable
Recruiting
- Conditions
- Myasthenia gravis
- Registration Number
- JPRN-UMIN000007671
- Lead Sponsor
- Department of Neurology, Chiba University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
Patients disqualified by doctor in attendance with any reason
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percentage of the patients taking prednisolone less than 5mg/day and maintaining with Minimal Manifestations after 2 years
- Secondary Outcome Measures
Name Time Method